Cover Image

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infections occurring in healthcare workers after booster vaccination: A comparison of delta versus omicron variants

In this study, we used genomic sequencing to identify variants of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in healthcare workers with coronavirus disease 2019 (COVID-19) after receiving a booster vaccination. We compared symptoms, comorbidities, exposure risks, and vaccine history b...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kimberly D. Reeves (Author), Christopher M. Polk (Author), Laura A. Cox (Author), Robert T. Fairman (Author), Gregory A. Hawkins (Author), Catherine L. Passaretti (Author), Mindy M. Sampson (Author)
Format:	Book
Published:	Cambridge University Press, 2022-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A comparison of severity of illness between the SARS-CoV-2 Omicron variant and Delta variant
by: Laura Peyton Ellis, et al.
Published: (2023)

Comparison of the causes of death associated with delta and Omicron SARS-CoV-2 variants infection
by: A Reum Kim, et al.
Published: (2023)

Epidemiological characteristics of Omicron and Delta SARS-CoV-2 variant infection in Santiago, Chile
by: Andrea Mella-Torres, et al.
Published: (2022)

Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: A systematic review
by: Yuxuan Du, et al.
Published: (2022)

Breakthrough cases of Omicron and Delta variants of SARS-CoV-2 during the fifth wave in Pakistan
by: Zunera Jamal, et al.
Published: (2022)

Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update
by: Ranjan K. Mohapatra, et al.
Published: (2022)

Prognostic factors for the outcomes of COVID-19 patients infected with SARS-CoV-2 Omicron and Delta variants
by: Gunadi, et al.
Published: (2023)

COVID-19 Variants in Critically Ill Patients: A Comparison of the Delta and Omicron Variant Profiles
by: Alberto Corriero, et al.
Published: (2022)

Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years
by: Enagnon Kazali Alidjinou, et al.
Published: (2022)

Virofree, an Herbal Medicine-Based Formula, Interrupts the Viral Infection of Delta and Omicron Variants of SARS-CoV-2
by: Ly Hien Doan, et al.
Published: (2022)

Prevalence and associating factors of long COVID in pediatric patients during the Delta and the Omicron variants
by: Tananya Lokanuwatsatien, et al.
Published: (2023)

Spread of the delta coronavirus variant: Africa must be on watch
by: Melody Okereke
Published: (2021)

Outcomes of patients hospitalized for COVID-19, secondary infections, antimicrobial use during SARS-CoV-2 delta and omicron variants
by: Swetha Srialluri, et al.
Published: (2023)

Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
by: Sivaprakasam T. Selvavinayagam, et al.
Published: (2022)

Using SCENTinel® to predict SARS-CoV-2 infection: insights from a community sample during dominance of Delta and Omicron variants
by: Stephanie R. Hunter, et al.
Published: (2024)

SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines
by: Camilo C. Roa, et al.
Published: (2024)

Effectiveness of the pre-Omicron COVID-19 vaccines against Omicron in reducing infection, hospitalization, severity, and mortality compared to Delta and other variants: A systematic review
by: Pradipta Paul, et al.
Published: (2023)

Is the Delta Plus Variant (B.1.617.2/AY1) more serious than the Delta Variant?
by: Mohana Priya Kunasekaran, et al.
Published: (2021)

General practitioner visits after SARS-CoV-2 omicron compared with the delta variant in children in Norway: a prospective nationwide registry study
by: Siri Eldevik Håberg, et al.
Published: (2022)

Ursodeoxycholic acid may protect from severe acute respiratory syndrome coronavirus 2 Omicron variant by reducing angiotensin‐converting enzyme 2
by: Kyungmin Lee, et al.
Published: (2024)

Chimeric mRNA-based COVID-19 vaccine induces protective immunity against Omicron and Delta variants
by: Qidong Hu, et al.
Published: (2022)

Effects of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) Delta variant (B.1.617.2) on maternal and neonatal outcomes
by: Kalsang Dolma, et al.
Published: (2023)

Omicron variant in the current SARS-CoV-2 pandemic
by: Kaveh Nasiri, et al.
Published: (2022)

Updated report of COVID-19 vaccine safety monitoring in Japan: booster doses for Omicron variants and vaccinations for infants and young children
by: Toshihiro Yamaguchi, et al.
Published: (2023)

SARS-CoV-2 B.1.1.529 (Omicron) Variant Causes an Unprecedented Surge in Children Hospitalizations and Distinct Clinical Presentation Compared to the SARS-CoV-2 B.1.617.2 (Delta) Variant
by: Jessica Taytard, et al.
Published: (2022)

Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico
by: Marcela Peña Rodríguez, et al.
Published: (2023)

Shift in SARS-CoV-2 variants of concern from Delta to Omicron was associated with reduced hospitalizations, increased risk of breakthrough infections but lesser disease severity
by: Fridah Mwendwa, et al.
Published: (2024)

Transmissibility, hospitalization, and intensive care admissions due to omicron compared to delta variants of SARS-CoV-2 in Catalonia: A cohort study and ecological analysis
by: Martí Català, et al.
Published: (2022)

Symptom trajectories of post-COVID sequelae in patients with acute Delta or Omicron infection in Bergen, Norway
by: Arild Iversen, et al.
Published: (2024)

Severe COVID-19 outcomes in pediatrics: An observational cohort analysis comparing Alpha, Delta, and Omicron variantsResearch in context
by: Amit Bahl, et al.
Published: (2023)

Optimization of COVID-19 prevention and control measures based on prevalence characteristics of SARS-CoV-2 Delta and Omicron variants: an analysis on surveillance data of Ningbo city
by: Yan-ru CHU, et al.
Published: (2022)

Corrigendum: Transmissibility, hospitalization, and intensive care admissions due to omicron compared to delta variants of SARS-CoV-2 in Catalonia: A cohort study and ecological analysis
by: Martí Català, et al.
Published: (2022)

Effect of Tocilizumab on Mortality in Patients with SARS-CoV-2 Pneumonia Caused by Delta or Omicron Variants: A Propensity-Matched Analysis in Nimes University Hospital, France
by: Paul Laffont-Lozes, et al.
Published: (2023)

A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and children
by: Frances Priddy, et al.
Published: (2024)

Overlapping Delta and Omicron Outbreaks During the COVID-19 Pandemic: Dynamic Panel Data Estimates
by: Alexander L Lundberg, et al.
Published: (2022)

Importation of SARS-CoV-2 Omicron variant in Beijing, China
by: Fu Li, et al.
Published: (2022)

Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant
by: Nirmitee Mulgaonkar, et al.
Published: (2023)

Methicillin-resistant Staphylococcus aureus mupirocin resistance rates in a large healthcare system
by: Mindy Sampson, et al.
Published: (2023)

Relationships between COVID-19 healthcare outcomes and county characteristics in the U.S. for Delta (B.1.617.2) and Omicron (B.1.1.529 and BA.1.1) variants
by: Alexander A. Bruckhaus, et al.
Published: (2023)

Treatment with Sotrovimab and Casirivimab/Imdevimab Enhances Serum SARS-CoV-2 S Antibody Levels in Patients Infected with the SARS-CoV-2 Delta, Omicron BA.1, and BA.5 Variants
by: Kana Fujimoto, et al.
Published: (2022)